The Cooper Companies, Inc.
General ticker "COO" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $16.1B (TTM average)
The Cooper Companies, Inc. does not follow the US Stock Market performance with the rate: -2.0%.
Estimated limits based on current volatility of 1.4%: low 75.93$, high 78.10$
Factors to consider:
- Company included in S&P500 list
- Total employees count: 970 as of 1993
- US accounted for 50.5% of revenue in the fiscal year ended 2024-10-31
- Top business risk factors: Economic downturns and volatility, Inflation impact, Geopolitical risks, Manufacturing disruptions, Litigation risks
- Current price 23.1% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-10-31 to 2026-10-31
- 2024-10-31 to 2025-10-31 estimated range: [94.32$, 125.15$]
- 2025-10-31 to 2026-10-31 estimated range: [100.15$, 133.28$]
Financial Metrics affecting the COO estimates:
- Negative: with PPE of 28.7 at the end of fiscal year the price was very high
- Positive: 7.86 < Operating profit margin, % of 18.12
- Positive: Inventory ratio change, % of 0.17 <= 0.84
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 3.09
- Positive: 0.33 < Operating cash flow per share per price, % of 3.36
- Positive: -4.48 < Investing cash flow per share per price, % of -3.62
- Negative: 0.01 < Interest expense per share per price, % of 0.54
Short-term COO quotes
Long-term COO plot with estimates
Financial data
| YTD | 2022-10-31 | 2023-10-31 | 2024-10-31 |
|---|---|---|---|
| Operating Revenue | $3,308.40MM | $3,593.20MM | $3,895.40MM |
| Operating Expenses | $2,800.80MM | $3,060.10MM | $3,189.70MM |
| Operating Income | $507.60MM | $533.10MM | $705.70MM |
| Non-Operating Income | $-32.30MM | $-120.20MM | $-123.40MM |
| Interest Expense | $57.30MM | $105.30MM | $114.30MM |
| R&D Expense | $110.30MM | $137.40MM | $155.10MM |
| Income(Loss) | $475.30MM | $412.90MM | $582.30MM |
| Taxes | $89.50MM | $118.70MM | $190.00MM |
| Profit(Loss)* | $385.80MM | $294.20MM | $392.30MM |
| Stockholders Equity | $7,174.50MM | $7,550.80MM | $8,083.40MM |
| Inventory | $628.70MM | $735.60MM | $802.70MM |
| Assets | $11,492.30MM | $11,658.90MM | $12,315.20MM |
| Operating Cash Flow | $692.40MM | $607.50MM | $709.30MM |
| Capital expenditure | $242.00MM | $392.50MM | $421.20MM |
| Investing Cash Flow | $-1,831.20MM | $-449.00MM | $-764.60MM |
| Financing Cash Flow | $1,193.70MM | $-173.90MM | $39.20MM |
| Earnings Per Share** | $1.96 | $1.49 | $1.97 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.